Zyprexa Sales Data
Last updated: February 2014 (updated quarterly).
The following data shows Zyprexa U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2012 | 84 ( 43) |
$194,460 | -48.69% | 325 | -47.07% |
| Q4 2011 | 41 (28) |
$379,000 | -54.28% | 614 | -54.89% |
| Q3 2011 | 13 (2) |
$828,973 | -4.04% | 1,361 | -7.60% |
| Q2 2011 | 11 ( 2) |
$863,890 | 7.93% | 1,473 | -1.14% |
| Q1 2011 | 13 | $800,446 | n/a | 1,490 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
